4//SEC Filing
Levitz Michael L 4
Accession 0001171843-23-005271
CIK 0000898437other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:30 PM ET
Size
9.3 KB
Accession
0001171843-23-005271
Insider Transaction Report
Form 4
Levitz Michael L
EVP, CFO, Treasurer
Transactions
- Tax Payment
Common Stock
2023-08-10$18.58/sh−1,133$21,051→ 33,232 total - Exercise/Conversion
Common Stock
2023-08-10+3,859→ 34,365 total - Exercise/Conversion
Restricted Stock Unit
2023-08-10−3,859→ 0 totalExercise: $0.00→ Common Stock (3,859 underlying)
Footnotes (5)
- [F1]Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020.
- [F2]Includes 668 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 12, 2023.
- [F3]Reflects an aggregate of 1,133 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on August 10, 2023.
- [F4]Reflects the closing price of ANIK common stock on August 10, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001468019
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:30 PM ET
- Size
- 9.3 KB